Literature DB >> 8868001

Metabolism of barnidipine hydrochloride, a potent calcium antagonist, in rat and dog.

T Teramura1, T Tokunaga, H Matsumoto, T Watanabe, S Higuchi.   

Abstract

1. In vitro experiments in the rat indicated that barnidipine was metabolized extensively in the liver and was catalyzed by P450s. 2. After oral dosing, nine metabolites were identified in the urine and bile of rat and dog. No unchanged drug was detected in urine and bile. Ester hydrolysis and pyridine formation were the main metabolic pathways in urine in both species, whereas glucuronide conjugates of the debenzylated metabolite and the hydrolyzed pyrrolidine ester were noted in bile. 3. The metabolism of barnidipine in the rat and dog were qualitatively similar. Metabolites are generated by one or several of the following pathways: (a) N-debenzylation of the side chain, (b) hydrolysis of the pyrrolidine ester, (c) oxidation of the dihydropyridine ring to a pyridine ring, (d) hydrolysis of the methylester, (e) reduction of the nitro group to the amino group, and (f) conjugation of the generated metabolites with glucoronic acid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8868001     DOI: 10.3109/00498259609046698

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  2 in total

Review 1.  Barnidipine.

Authors:  H S Malhotra; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Urinary excretion of the 1,4-dihydropyridine calcium antagonist VULM 993 and its metabolites in the rat.

Authors:  M Stefek; V Faberova; S Musil; I Kakalik
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.